Position in BBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$88,760,199
+$47,447,579 QoQ
Shares Held
1,191,732
+114.2% QoQ
Ownership
0.610%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#40
of 473 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Dec 31, 2025CallValue
$527,781
CallShares
6,900
PutValue
$351,854
PutShares
4,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. BBIO ranks #2 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
This page
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in BBIO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,760,199 | 1,191,732 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $41,312,620 | 556,324 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $351,854 | 4,600 | Put | Defined | 2026-02-13 | |
| 2025-12-31 | $527,781 | 6,900 | Call | Defined | 2026-02-13 | |
| 2025-12-31 | $20,568,084 | 268,899 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,220,590 | 23,500 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $820,652 | 15,800 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $945,642 | 21,900 | Put | Defined | 2025-08-27 | |
| 2025-03-31 | $791,653 | 22,900 | Put | Defined | 2025-08-27 | |
| 2024-06-30 | $6,403,246 | 252,793 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $3,229,559 | 79,999 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,417,660 | 167,526 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,422,085 | 257,098 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,104,677 | 247,568 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $280,065 | 36,754 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,839,520 | 285,666 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,086,812 | 119,693 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,453,297 | 143,182 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,475,696 | 88,471 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,089,230 | 44,575 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,553,187 | 41,883 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,363,084 | 22,128 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,445,097 | 20,322 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $585,124 | 15,595 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $565,326 | 17,336 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||